Letter to the editor: The addition of C‐reactive protein and von Willebrand factor to Model for End‐Stage Liver Disease‐Sodium

With great interest, we read a study about a novel model modification for end-stage liver disease-sodium (MELD).(1) Starlinger P and colleagues concluded that the addition of C-reactive protein (CRP) and von Willebrand factor antigen (vWF-Ag) to the Model for End-Stage Liver Disease-Sodium (MELD-Na) improves the prediction of waitlist mortality. However, several crucial concerns attached our due attention.